New SEC Form D filing
BIOVENTRIX, INC., 2026-10-08
A new SEC Form D private-offering notice from Mansfield, MA, a $3,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Developer of the Revivent System, a minimally invasive cardiac remodeling device for heart failure patients.
Filed 2026-10-08Filed to raise $3,000,000First money in 2026-09-29Raised so far $1,200,000HQ (as filed) Mansfield, MASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified bioventrix.com↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Soterya, Inc., 2026-10-13, $2M, Boston, MA
- Andira Medicine Inc., 2026-10-09, $120K, North Vancouver, BC, Canada
- Axelyf, Inc., 2026-10-13, $2.7M, Chestnut Hill, MA
- HCW Biologics Inc., 2026-10-08, $1.5M, Miramar, FL
- Arkea Bio Corp., 2026-10-09, $33M, Charlestown, MA
- OncoNano Medicine, Inc., 2026-10-08, $15M, Dallas, TX
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.